Ferroptosis-centered Drug Response Information
General Information of the Drug (ID: ferrodrug0052)
Name |
Tetrachlorobenzoquinone
|
||||
---|---|---|---|---|---|
Synonyms |
Chloranil; 118-75-2; p-Chloranil; Tetrachloro-p-benzoquinone; Tetrachloro-1,4-benzoquinone; 2,3,5,6-tetrachlorocyclohexa-2,5-diene-1,4-dione; Spergon; Tetrachlorobenzoquinone; Vulklor; Coversan; Reranil; Tetrachloroquinone; 2,3,5,6-TETRACHLORO-1,4-BENZOQUINONE; Khloranil; Psorisan; Tetrachloro-p-quinone; Tetrachloroparabenzoquinone; Spergon technical; Spergon I; Chloranile; Quinone tetrachloride; 2,3,5,6-Tetrachloro-p-benzoquinone; Geigy-444E; 2,3,5,6-Tetrachlorobenzo-1,4-quinone; 2,3,5,6-Tetrachloro-2,5-cyclohexadiene-1,4-dione; Dow Seed Disinfectant No. 5; 2,5-Cyclohexadiene-1,4-dione, 2,3,5,6-tetrachloro-; 2,3,5,6-Tetrachloroquinone; ENT 3,797; G-444E; alpha-Chloranil; p-Benzoquinone, 2,3,5,6-tetrachloro-; 2,3,5,6-Tetrachlorobenzoquinone; NSC 8432; .alpha.-Chloranil; G-25804; 1,4-Benzoquinone, 2,3,5,6-tetrachloro-; tetrachlorocyclohexa-2,5-diene-1,4-dione; 01W5X7N5XV; DTXSID2020266; CHEBI:36703; NSC-8432; 2,3,5,6-Tetrachlor-1,4-benzochinon; 2,3,5,6-tetrachloro-[1,4]benzoquinone; DTXCID20266; Caswell No. 171; CAS-118-75-2; CCRIS 7155; HSDB 1533; EINECS 204-274-4; EPA Pesticide Chemical Code 079301; UNII-01W5X7N5XV; para-chloranil; AI3-03797; Tetrachlorquinone; tetrachloro-1; 4-Chloranil; MFCD00001594; P-CHLORONIL; Spectrum_001590; SpecPlus_000850; CHLORANIL [MI]; CHLORANIL [HSDB]; Spectrum2_000024; Spectrum3_001660; Spectrum4_000794; Spectrum5_001386; 2,5,6-Tetrachloroquinone; EC 204-274-4; CHLORANIL [WHO-DD]; SCHEMBL24049; BSPBio_003419; KBioGR_001268; KBioSS_002070; Chloranil, analytical standard; DivK1c_006946; SPECTRUM1504212; SPBio_000087; 2,5,6-Tetrachlorobenzoquinone; CHEMBL192627; BDBM22782; KBio1_001890; KBio2_002070; KBio2_004638; KBio2_007206; KBio3_002639; NSC8432; 2,5,6-Tetrachloro-p-benzoquinone; AMY12556; ENT 3797; WLN: L6V DVJ BG CG EG FG; p-Benzoquinone,3,5,6-tetrachloro-; Tox21_201656; Tox21_303021; CCG-39987; STK396683; Tetrachloro-1,4-benzoquinone, 99%; 2,5,6-Tetrachloro-1,4-benzoquinone; AKOS001569085; Chloranil, purum, >=97.0% (AT); 2,4-dione, 2,3,5,6-tetrachloro-; NCGC00091254-01; NCGC00091254-02; NCGC00091254-03; NCGC00091254-04; NCGC00091254-05; NCGC00256410-01; NCGC00259205-01; AC-11776; AS-14117; BP-30129; 2,3,5,6-Tetrachlorobenzo-1,4-quinone #; C1770; CS-0013526; FT-0609408; T0061; Chloranil, PESTANAL(R), analytical standard; EN300-18125; C18933; D72499; 2,5,6-Tetrachloro-2,5-cyclohexadiene-1,4-dione; A804087; Q629632; Z57188200; InChI=1/C6Cl4O2/c7-1-2(8)6(12)4(10)3(9)5(1)1
Click to Show/Hide
|
||||
Status |
Investigative
|
||||
Drug Type |
Small molecular drug
|
||||
Structure |
![]() |
||||
Formula |
C6Cl4O2
|
||||
IUPAC Name |
2,3,5,6-tetrachlorocyclohexa-2,5-diene-1,4-dione
|
||||
Canonical SMILES |
C1(=C(C(=O)C(=C(C1=O)Cl)Cl)Cl)Cl
|
||||
InChI |
InChI=1S/C6Cl4O2/c7-1-2(8)6(12)4(10)3(9)5(1)11
|
||||
InChIKey |
UGNWTBMOAKPKBL-UHFFFAOYSA-N
|
||||
PubChem CID | |||||
TTD Drug ID |
Full List of Ferroptosis Target Related to This Drug
Transferrin receptor protein 1 (TFRC)
In total 1 item(s) under this Target | ||||
Experiment 1 Reporting the Ferroptosis-centered Drug Act on This Target | [1] | |||
Target for Ferroptosis | Marker/Suppressor/Driver | |||
Responsed Disease | Hereditary Leiomyomatosis | ICD-11: 2C90 | ||
Pathway Response | Fatty acid metabolism | hsa01212 | ||
Ferroptosis | hsa04216 | |||
Apoptosis | hsa04210 | |||
Cell Process | Cell ferroptosis | |||
Cell apoptosis | ||||
In Vitro Model | PC12 cells | Adrenal gland pheochromocytoma | Rattus norvegicus | CVCL_0481 |
Response regulation | Tetrachlorobenzoquinone (TCBQ)-induced ferroptosis occurred as a result of iron accumulation and inhibition of GPX4 expression. Mechanistically, TCBQ promotes the iron import into cells by improving the expression of TF and TFR1, and the complex of TF and TFR1 is internalized by endocytosis in Adrenal gland pheochromocytoma. | |||
Phospholipid hydroperoxide glutathione peroxidase (GPX4)
In total 1 item(s) under this Target | ||||
Experiment 1 Reporting the Ferroptosis-centered Drug Act on This Target | [1] | |||
Target for Ferroptosis | Suppressor | |||
Responsed Disease | Hereditary Leiomyomatosis | ICD-11: 2C90 | ||
Pathway Response | Fatty acid metabolism | hsa01212 | ||
Ferroptosis | hsa04216 | |||
Apoptosis | hsa04210 | |||
Cell Process | Cell ferroptosis | |||
Cell apoptosis | ||||
In Vitro Model | PC12 cells | Adrenal gland pheochromocytoma | Rattus norvegicus | CVCL_0481 |
Response regulation | Tetrachlorobenzoquinone (TCBQ)-induced ferroptosis occurred as a result of iron accumulation and inhibition of GPX4 expression. Mechanistically, TCBQ promotes the iron import into cells by improving the expression of TF and TFR1, and the complex of TF and TFR1 is internalized by endocytosis in Adrenal gland pheochromocytoma. | |||